Key Highlights RKLB shares climbed approximately 7% following Cantor Fitzgerald’s reaffirmation of a Buy rating June 22 Nasdaq-100 addition identified as major catalyst, likely triggering pas
Key Highlights
- RKLB shares climbed approximately 7% following Cantor Fitzgerald’s reaffirmation of a Buy rating
- June 22 Nasdaq-100 addition identified as major catalyst, likely triggering passive investment inflows
- KeyBanc elevated RKLB to Overweight, setting a $135 target that suggests over 30% upside
- Recent selloff attributed to capital reallocation following SpaceX’s Nasdaq listing, not operational concerns
- Analyst consensus shows Strong Buy rating with mean target of $108.70 and upper target reaching $150
Rocket Lab (RKLB) experienced a robust 7% gain on Monday following encouraging analyst commentary from two prominent Wall Street firms. Cantor Fitzgerald maintained its Overweight stance, while KeyBanc delivered a new upgrade — offering compelling entry points for investors after the stock tumbled 11% on June 12.
Rocket Lab USA, Inc., RKLB
The space company’s shares currently trade approximately 27% below their 2024 peak reached in late May.
Cantor Fitzgerald’s Andres Sheppard emphasized June 22 as a pivotal milestone. On this date, Rocket Lab enters the Nasdaq-100 Index. This transition elevates the firm’s visibility among institutional capital and compels index-tracking funds and ETFs to establish positions.
Sheppard characterized RKLB’s Nasdaq-100 membership as “material” — a characterization that appears well-founded given current market dynamics.
Beyond index membership, Sheppard identified several “material moats” distinguishing Rocket Lab from emerging rivals. These advantages encompass an established launch history, a three-vehicle portfolio (Electron, HASTE, and the forthcoming Neutron), a diversified customer mix spanning commercial and government sectors, and operational launch facilities in New Zealand and the United States.
Sheppard holds position 1,456 among more than 12,200 analysts monitored by TipRanks, maintaining a perfect 100% success record on RKLB with average returns of 196.92% per recommendation over one year.
KeyBanc Makes the Bull Case After Recent Weakness
KeyBanc’s Michael Leshock elevated RKLB to Overweight, establishing a $135 price objective — signaling greater than 30% appreciation potential from prior closing levels. His investment rationale focuses on the notion that recent price weakness stemmed from market dynamics rather than operational deterioration.
Following SpaceX‘s landmark Nasdaq introduction, institutional portfolios rushed to secure positions in the newly traded aerospace leader. This necessitated liquidating current space sector allocations — Rocket Lab among them. Leshock characterized this as rotation-driven pressure unrelated to fundamental performance.
He identified a persistent structural deficit in launch availability that he anticipates will sustain market undersupply beyond a decade. Accelerating demand for satellite networks and expanding global defense investment in space capabilities reinforce this outlook.
Rocket Lab concluded the first quarter with a contract backlog surpassing $2.2 billion. The enterprise is also competing for prominent opportunities including NASA’s Mars Telecommunications Orbiter initiative.
Vertical Integration Strategy Provides Competitive Advantage
Leshock underscored Rocket Lab’s vertically integrated business model as a critical competitive strength. With approximately 90 successful Electron launches and increasing clarity surrounding its Neutron medium-class vehicle development, he noted the organization demonstrates “institutional-grade” operational capability.
He views RKLB as shielding itself from conventional small-launch provider risks through greater supply chain ownership — an approach reflecting SpaceX’s proven strategic framework.
Wall Street consensus positions Rocket Lab as the definitive second-place player in commercial space behind SpaceX.
Analyst consensus on RKLB stands at Strong Buy, comprising 10 Buy recommendations and three Hold ratings. The mean price objective is $108.70, with the upper-range target at $150 — indicating approximately 37% potential appreciation from present trading levels.
The post Rocket Lab (RKLB) Stock Surges 7% on Analyst Upgrades and Nasdaq-100 Addition appeared first on Blockonomi.